Immunomodulators after the discontinuation of anti-tumor necrosis factor-alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study.
Asonuma K, Ozeki K, Yamazaki H, Okabayashi S, Okano S, Ozaki R, Nishimata N, Kiyohara H, Ichinari N, Kobayashi T, Yamada M, Matsubayashi M, Yokoyama Y, Arimitsu S, Umeno J, Munetomo Y, Andoh A, Shinzaki S; IBD Terakoya Group.
Asonuma K, et al.
J Gastroenterol Hepatol. 2024 Jan;39(1):66-73. doi: 10.1111/jgh.16376. Epub 2023 Oct 12.
J Gastroenterol Hepatol. 2024.
PMID: 37823425